Chronic Lymphocytic Leukemia Fund Grant

Chronic Lymphocytic Leukemia Fund Grant

Status: ACTIVE
Funder: Healthwell Foundation
Amount: Up to US $8,000
Last Updated: February 07, 2026

Summary

The Chronic Lymphocytic Leukemia Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients battling chronic lymphocytic leukemia (CLL). This fund provides essential support for prescription copays and premiums, ensuring that patients can access necessary treatments without the stress of financial constraints. Since its inception, the foundation has awarded over $1.2 billion in grants, helping more than 1.1 million patients. The initiative emphasizes the importance of accessible healthcare and aims to improve the quality of life for those affected by this condition.

Overview

Note:  If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. What We Do Our Mission: To reduce financial barriers to care for underinsured patients with chronic or life-altering diseases. The HealthWell Foundation is a leading independent non-profit dedicated to improving access to health care for America’s underinsured. When health insurance is not enough, we fill the gap by assisting with copays, premiums, deductibles and out-of-pocket expenses. In 2024, we awarded more than $1.2 billion in grants through our Disease Funds, and since 2004 we have helped more than 1,100,000 patients afford essential treatments and medications. HealthWell is recognized as one of America’s most efficient charities — 100 percent of every dollar donated goes directly to patient grants and services. We provide financial assistance to help with: Prescription copaysHealth insurance premiums, deductibles and coinsurancePediatric treatment costsTravel costsBehavioral health services Our Vision: To ensure that no patient goes without health care because they cannot afford it. Chronic Lymphocytic Leukemia About Chronic Lymphocytic Leukemia Leukemia is cancer that starts in the blood-forming cells of the bone marrow. When one of these cells changes and becomes a leukemia cell, it no longer matures the way it should and grows out of control. Often, it divides to make new cells faster than normal. According to the American Cancer Society, chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. CLL starts in cells that become certain white blood cells (called lymphocytes) in the bone marrow. The cancer (leukemia) cells start in the bone marrow but then go into the blood. In CLL, the leukemia cells often build up slowly. Over time, the cells grow and spread to other parts of the body, including the lymph nodes, liver, and spleen. Fund Definition Assistance with the prescription drugs and biologics used in the treatment of chronic lymphocytic leukemia. Grant Utilization HealthWell estimates that patients use an average of $3,200 during their 12-month grant period for this disease area. Assistance Type Prescription Drug CopayInsurance premium (Medicare Part B only) Maximum Award Level $8,000 Pharmacy Card Fund Yes Minimum Copay Reimbursement Amount None Minimum Premium Reimbursement Amount None Treatments Covered AlemtuzumabArzerraBelrapzoBendamustine HydrochlorideBendekaBetamethasoneBetamethasone Acetate-betamethasone Sodium PhosphateBetamethasone Sodium PhosphateBreyanziBrukinsaCalquenceCelestone SoluspanChlorambucilCladribineCopiktraCortefCortisone AcetateCyclophosphamideCytarabineDecadronDex24DexamethasoneDexamethasone Sodium PhosphateDoxorubicin HydrochlorideDuvelisibDxevoEtopophosEtoposideEtoposide PhosphateFludarabine PhosphateFusilevGazyvaHemadyHidexHydrocortisoneHydrocortisone Sodium SuccinateIbutrinibIdamycin PfsIdarubicin HydrochlorideIdelalisibImbruvicaJaypircaJylamvoKenalog-10KeytrudaKhapzoryLemtradaLenalidomideLeucovorin CalciumLeukeranLevoleucovorinLevoleucovorin CalciumLisocabtagene MaraleucelMechlorethamine HydrochlorideMedrolMethotrexateMethylprednisoloneMethylprednisolone Sodium SuccinateMillipredNipentNivolumabObinutuzumabOpdivoOrapred OdtOtrexupOxaliplatinPediapredPembrolizumabPentostatinPirtobrutinibPrednisolonePrednisolone Sodium PhosphatePrednisonePro-c-dure 5 KitRasuvoRayosRevlimidRiabniRituxanRituxan HycelaRituximabRituximab And Hyaluronidase HumanRituximab-abbsRituximab-arrxRituximab-pvvrRuxienceSolu-cortefSolu-medrolTaperdexTevimbraTislelizumab-jsgrTreandaTrexallTriamcinoloneTruximaVenclextaVenetoclaxVeripred 20Vincristine SulfateVivimustaXatmepZ-cort 7-dayZanubrutinibZydelig

Eligibility

You can learn more about this opportunity by visiting the funder's website. Do I Qualify?HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:You are being treated for Chronic Lymphocytic Leukemia.We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature.The patient must receive treatment in the United States.You have insurance and it covers your medication.To qualify for copayment assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. Please note that in order to qualify for premium assistance through this fund, you must have Medicare Part B. Your income falls within our guidelines.HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level.Household Income Limit500% of the Federal Poverty Level(adjusted for household size and high cost of living areas)The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.You are receiving treatment in the United States.Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.

Ineligibility

The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.